Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Revenue: 2010-2024

Historic Revenue for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $4.5 million.

  • China Pharma Holdings' Revenue fell 31.26% to $756,217 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 26.92%. This contributed to the annual value of $4.5 million for FY2024, which is 35.41% down from last year.
  • China Pharma Holdings' Revenue amounted to $4.5 million in FY2024, which was down 35.41% from $7.0 million recorded in FY2023.
  • Over the past 5 years, China Pharma Holdings' Revenue peaked at $10.9 million during FY2020, and registered a low of $4.5 million during FY2024.
  • For the 3-year period, China Pharma Holdings' Revenue averaged around $6.5 million, with its median value being $7.0 million (2023).
  • Data for China Pharma Holdings' Revenue shows a maximum YoY crashed of 35.41% (in 2024) over the last 5 years.
  • China Pharma Holdings' Revenue (Yearly) stood at $10.9 million in 2020, then dropped by 11.27% to $9.6 million in 2021, then dropped by 15.95% to $8.1 million in 2022, then dropped by 13.48% to $7.0 million in 2023, then crashed by 35.41% to $4.5 million in 2024.